Cryo-Cell International, Inc. (CCEL)
4.42
+0.77
(+21.10%)
USD |
NYAM |
Oct 16, 16:00
4.34
-0.08
(-1.81%)
After-Hours: 20:00
Cryo-Cell International Research and Development Expense (Annual) : 0.3763M for Nov. 30, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| November 30, 2025 | 0.3763M |
| November 30, 2024 | 1.242M |
| November 30, 2023 | 1.172M |
| November 30, 2022 | 0.3848M |
| November 30, 2021 | 0.0499M |
| November 30, 2020 | 0.0239M |
| November 30, 2019 | 0.0301M |
| November 30, 2018 | 0.0918M |
| November 30, 2017 | 0.0412M |
| November 30, 2016 | 0.0531M |
| November 30, 2015 | 0.0458M |
| November 30, 2014 | 0.0644M |
| November 30, 2013 | 0.0362M |
| November 30, 2012 | 0.1096M |
| November 30, 2011 | 0.184M |
| Date | Value |
|---|---|
| November 30, 2010 | 0.133M |
| November 30, 2009 | 0.1024M |
| November 30, 2008 | 0.1945M |
| November 30, 2007 | 0.5455M |
| November 30, 2006 | 0.4862M |
| November 30, 2005 | 0.0261M |
| November 30, 2004 | 0.0825M |
| November 30, 2003 | 0.227M |
| November 30, 2002 | 0.2197M |
| November 30, 2001 | 0.0511M |
| November 30, 2000 | 0.2758M |
| November 30, 1999 | 0.091M |
| November 30, 1998 | 0.3527M |
| November 30, 1997 | 0.2041M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Dogecoin Cash, Inc. | -- |
| Privia Health Group, Inc. | -- |
| Strata Critical Medical, Inc. | 3.052M |
| DocGo, Inc. | 13.56M |
| Syra Health Corp. | 0.0678M |